Recombinant Hepatitis C Virus NS3 (1450-1643), Biotin Labeled
Source : The E.coli derived recombinant Biotin Labeled protein contains the HCV NS3 immunodominant regions, a.a. 1450-1643, 22 kDa. The Biotin labeled protein is fused with b-galactosidase (114 kDa) at N-terminus. HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes (1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6) .
Product Specifications
Purification
HCV NS3 Biotin labeled protein is >95% pure as determined by 10% PAGE (coomassie staining) .
Components
8M urea, 20mM Tris-HCl pH 8.0, 10mM b-mercaptoethanol.
Storage Conditions
HCV NS3 Biotin although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NOB1, CT (NOB1, ART4, NOB1P, PSMD8BP1, RNA-binding protein NOB1, Phosphorylation regulatory protein HP-10, Protein ART-4) (FITC)
NOB1, CT (NOB1, ART4, NOB1P, PSMD8BP1, RNA-binding protein NOB1, Phosphorylation regulatory protein HP-10, Protein ART-4) (FITC)